Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

REVERSE

In this page

Clinical Trial

NCT02652780 Completed
REVERSE

Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation.

Phase 3
Interventional

Disease

Disease type

Paediatric clinical trials

Orphan drug recognition

No

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/02/2016

Closing date

31/01/2018

Inclusion criteria :

More

Exclusion criteria :

More

Funding

industry

Members involved

Main investigators

Others investigators

Dr Catherine Vignal-Clermont

France

Neuro-Ophthalmology Rare Diseases (WG2)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Principal investigators

HCP : Others investigators